Brett Fishbin

Stock Analyst at Keybanc

(3.82)
# 740
Out of 4,761 analysts
29
Total ratings
56%
Success rate
10%
Average return

Stocks Rated by Brett Fishbin

ResMed
Jan 31, 2025
Maintains: Overweight
Price Target: $266$280
Current: $231.69
Upside: +20.85%
Simulations Plus
Jan 24, 2025
Maintains: Overweight
Price Target: $35$37
Current: $31.77
Upside: +16.46%
Integer Holdings
Jan 24, 2025
Maintains: Overweight
Price Target: $144$154
Current: $129.87
Upside: +18.58%
Inspire Medical Systems
Jan 24, 2025
Reiterates: Overweight
Price Target: $236$234
Current: $177.32
Upside: +31.96%
Alcon
Jan 24, 2025
Maintains: Overweight
Price Target: $107$105
Current: $90.31
Upside: +16.27%
ICU Medical
Nov 13, 2024
Maintains: Overweight
Price Target: $198$209
Current: $157.26
Upside: +32.90%
STERIS
Sep 3, 2024
Maintains: Overweight
Price Target: $255$265
Current: $220.56
Upside: +20.15%
UFP Technologies
Feb 6, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $254.56
Upside: -
Sotera Health Company
Feb 6, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $13.52
Upside: -
LeMaitre Vascular
Feb 6, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $99.54
Upside: -
Initiates: Sector Weight
Price Target: n/a
Current: $88.48
Upside: -